Dyslipidemia Flashcards
Chylomicrons carry fats absorbed in the ____
Diet
VLDL carries fats from the ____
Liver
LDL is “___” cholesterol
Bad
HDL is the “____” cholesterol
Good
Lipoproteins are spherical particles that transport ____ molecules, principally cholesterol and triglycerides
Hydrophobic
The surface of chylomicrons is composed of a monolayer of ____ and unesterified cholesterol molecules
Phospholipid
Apolipoprotein B-100 carries ____ to tissues
Cholesterol
The goal for apolipoprotein B-100 is < ____ mg/dl for high-risk individuals
80
Apolipoprotein B-100 levels may be a better indicator of ____ ____ risk than total cholesterol or LDL
Cardiac disease
Exogenous cholesterol and triglycerides are simultaneously absorbed from the ____ ____ by different mechanisms
Intestinal lumen
Cholesterol is taken up from micelles across a regulatory channel named ____
NPC1L1
A fraction of the cholesterol is pumped back into the lumen by ____, a heterodimeric ATP-dependent plasma membrane protein
ABCG5/G8
The remainder of cholesterol is converted to cholesteryl esters by ____
ACAT
Triglycerides are taken up as ___ ___ and ____, which are re-esterified by DGAT
Fatty acids, monoglycerides
Formation of ____ occurs when IDL particles interact with hepatic lipase to become denser and cholesteryl ester-enriched
LDL
When LDL is formed, both ___ and ____ lose affinity for the particle and are transferred to HDL, leaving only apoB1000
apoE and apoCII
The binding of apolipoprotein B100 to LDL receptors on hepatocytes or other cell types promotes LDL internalization into endocytic vesicles and fusion of the vesicles with ____
Lysosomes
LDL receptors are recycled to the cell surface, whereas lipoprotein particles are hydrolyzed into amino acids, releasing free _____
Cholesterol
Intracellular cholesterol has what 3 regulator effects on the cell?
-Cholesterol decreases the activity of HMG-CoA reductase, the rate-limiting enzyme in cholesterol biosynthesis
-Cholesterol activates acetyl CoA: cholesterol acyltransferase (ACAT), an enzyme that esterifies free cholesterol into cholesteryl esters for intracellular storage or export
-Cholesterol inhibits the transcription of the gene encoding the LDL receptor, and, thereby, decreases further uptake of cholesterol by the cell
Elevated LDL is a major risk factor for the development of _____
Atheroscleorosis
Native LDL that migrates into the subendothelial space can under chemical transformation to oxidized LDL via lipid peroxidation and fragmentation of _____
apoB100
Oxidized LDL has a number of deleterious effects on _____ function
Vascular
Oxidized LDL promotes monocytes chemotaxis to the ____ space and inhibits monocyte egress from that space
Subendothelial
Resident monocyte:macrophages bind to oxidized LDL via a scavenger receptor, resulting in the formation of lipid-laden ___ ___
Foam cells
Oxidized LDL can directly injure endothelial cells and cause endothelial _____
Dysfunction
Oxidized LDL can also cause foam cell ____, with a release of numerous proteolytic enzymes
Necrosis
Within a hepatocyte, a portion of cholesterol is concerted to ____ ____
Bile acids
The process of converting cholesterol to bile acids is rate-limited by ____ _____, which is expressed only in hepatocytes
Cholesterol 7a-hydroxylase
____ is the most abundant bile salt synthesized by the human liver
Cholate
What are some non-pharmacological treatments of dyslipidemia?
-Lifestyle and diet habits
-Low cholesterol, low-fat diet (12 weeks before starting drug treatment and continued thereafter)
-Weight loss program
-Exercising
-Evaluate for alcoholism (may be the cause of hyperlipidemia)
Options for the pharmacological treatment of dyslipidemia:
Inhibitors of HGM-CoA Reductase (statins):
-Lovastatin
-Simvastatin
-Fluvastatin
-Atorvastatin
-Pravastatin
-Rosuvastatin
-Pitavastatin
Adjuncts to hypertension treatment with dyslipidemia are based on patient cardiovascular risk:
-High-intensity statin
-Moderate-intensity statin
-Move away from LDL goals
-Move away from non-statins if patient can’t tolerate statin
What are high-intensity statins?
-Atorvastatin 40-80 mg
-Rosuvastatin 20-40 mg
What are examples of moderate-intensity statins?
-Simvastatin 20-40 mg
-Atorvastatin 10-20 mg
-Rosuvastatin 5-10 mg
-Lovastatin 40 mg
-Pravastatin 40-80 mg
-Pitavastatin 2-4 mg
-Fluvastatin 80 mg
Mechanism of action of statins:
-Block the rate-limiting step in the synthesis of cholesterol
-Molecular site of action: bind to and inhibit the enzyme HMG Co-A reductase, the rate-limiting enzyme in the synthesis of cholesterol by the hepatocytes
Statins competitively inhibit HMG-CoA reductase, the enzyme that catalyzes the rate limiting synthesis in ____ biosynthesis
Cholesterol
Decreased cellular cholesterol concentrations lead to _____ activation and cleavage of the sterol regulatory element binding protein, which is a transcription factor that normally resides in the cytoplasm
Protease
The cleaved sterol regulatory element binding protein diffuses into the nucleus, where it binds to sterol response elements, leading to up-regulation of ___-____ gene transcription
LDL-receptor
Up-regulation of LDL-receptor leads to ____ cellular LDL-receptor expression
Increased
The increased LDL receptor expression promotes uptake of LDL particles and results in reduced _____ concentrations in the plasma
LDL-cholesterol
The liver compensates for the reduced ability to synthesize cholesterol by ____ ___ cholesterol circulating in the blood in
Taking up
The reduction in the cholesterol concentration in the liver leads to an ____ in the number of LDL receptors inserted in the hepatocyte membrane
Increase
The goal for treatment of dyslipidemia is to increase the hepatic uptake of ____, which decreases the amount in circulation
LDL
Statins reduce LDL by ___-___%
20-55
Potency differs between statins; what is the most potent to least potent statin?
Ruvostatin > Atorvastatin > Simvastatin > Pravastatin (in ability to reduce LDL per equal dose)
Adverse effects of statins?
-Liver toxicity (low incidence, but would need to d/c drug)
-Myotoxicity
-Rhabdomyolysis
-Abdominal pain
-Nausea
-Headache
-Photosensitivity
How is liver toxicity evidenced by statins?
Increase in blood transaminase, an enzyme that is released from the liver when hepatocytes are damaged
Myotoxicity results from damage to ____ muscle cells and ranges from symptoms of myalgia (muscle pain) to rhabdomyolysis (deterioration and death of skeletal muscle cells)
Skeletal
Myotoxicity can be monitored by measuring blood levels of ____ ____, which is an enzyme that is released from damaged skeletal muscle cells
Creatine phosphokinase
____ is a syndrome characterized by muscle necrosis that causes intracellular constituents of the affected skeletal muscle to be released into the circulation
Rhabdomyolysis